Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT07327710

Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy

Efficacy and Safety of Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation in the Treatment of Peripheral Facial Palsy

Status
Enrolling By Invitation
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To evaluate the efficacy and safety of treating peripheral facial palsy using a non-invasive brain-computer interface combined with transcranial direct current stimulation (tDCS).

Detailed description

This study is mainly designed to compare the therapeutic efficacy of non-invasive brain-computer interface combined with transcranial direct current stimulation (tDCS), pulsed radiofrequency, and pharmacological treatment versus pulsed radiofrequency combined with pharmacological treatment in patients with peripheral facial palsy.

Conditions

Interventions

TypeNameDescription
PROCEDUREBrain-Computer Interface (BCI)1. BCI Therapy: Real-time feedback drives NMES (neuromuscular electrical stimulation) of the target facial muscles. Each session lasts 30 minutes, 3-5 times per week, for a total of 4 weeks. 2. tDCS Therapy: Applied to the regions corresponding to the branches of the facial nerve. A constant current (usually 0.5-2 mA) is delivered for 20-30 minutes per session, 5-20 sessions per course. Standard treatment frequency is once daily, 5-6 times per week, with a continuous course of 2-4 weeks. Each stimulation session typically lasts 20-30 minutes.
PROCEDUREPulsed Radiofrequency (PRF)Acute-phase "shock" protocol: Within 7 days of onset, a single pulsed radiofrequency treatment is applied to the extracranial segment of the facial nerve. Depending on recovery, the treatment may be repeated 1-2 weeks later. Chronic-phase (sequelae) "shock" protocol: Administered once every 1-4 weeks, for a total of 1-4 sessions.
OTHERStandard TherapyIncludes facial muscle function training, physiotherapy, hot and cold compresses, and neurotrophic drug treatment.

Timeline

Start date
2025-11-30
Primary completion
2027-12-31
Completion
2028-12-31
First posted
2026-01-08
Last updated
2026-01-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07327710. Inclusion in this directory is not an endorsement.